The National Health Surveillance Agency (Anvisa) ordered the recall of several batches of creatine and other IDNLABS brand supplements. The decision, taken last Friday (19), aims to protect consumer health by immediately suspending the sale, distribution and use of affected products throughout the national territory.
The measure was adopted after identifying several flaws in the items analyzed. Among the problems found, the regulatory agency pointed out that some products had a lower quantity of ingredients than declared on their packaging, while others had recommendations for use that went beyond the limits allowed by current legislation. In addition, unauthorized advertising claims were observed, which could mislead the consumer about the benefits or composition of the supplements.
Lots of supplements prohibited for sale by Anvisa
Anvisa’s determination covers different categories of IDNLABS supplements, with specific batches that are prevented from being sold. The agency emphasizes the importance of consumers checking batch numbers before purchasing or using these products.
- Creatine powder
* Lot 0148.05.2025;
* Lot 0285.05.2025;
* Lot 0147.05.2025.
- BCAA 2-1-1 Tablets
* Lot 003.01.2025;
* Lot 004.01.2025;
* Lot 044.01.2025.
- Beta Alanine Powder
* Lot 0267.08.2025;
* Lot 0149.05.2025;
* Lot 079.02.2025.
- Multivitamins and multiminerals in coated tablets
* Lots 005.01.2026;
* Lot 0211.07.2025.